A pharmaceutical composition comprising a pharmaceutically-acceptable carrier, a tramadol material and a phosphodiesterase (PDE) inhibitor, and a kit comprising a container holding a tramadol material and a phosphodiesterase (PDE) inhibitor or a first container holding a tramadol material and a second container holding a phosphodiesterase (PDE) inhibitor.